Parallel cyclin E and cyclin A expression in neoplastic lesions of the uterine cervix

British Journal of Cancer

Volumn 94, Issue 7, 2006, Pages 1045-1050

  Erlandsson, F ^a,b   Martinsson Ahlzen H S ^a   Wallin, K L ^a   Hellstrom A C ^a   Andersson, S ^a   Zetterberg, A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Box 5237   (Sweden)

Author keywords

Cell cycle; Cervical carcinoma; Cyclin E

Indexed keywords

BIOLOGICAL MARKER; CYCLIN A; CYCLIN E;

ADENOCARCINOMA; ARTICLE; CANCER CYTODIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CANCER SURVIVOR; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOFLUORESCENCE TEST; MICROSCOPY; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STAINING; SURVIVAL TIME; TISSUE SECTION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; BIOPSY; CASE-CONTROL STUDIES; CELL CYCLE; CYCLIN A; CYCLIN E; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 33645748245     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603038     Document Type: Article

References (21)

1. Andersson S, Rylander E, Larson B, Sigurdardottir S, Backlund I, Sallstrom J, Wilander E (2003) Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing. Oncol Rep 10: 175-179
2. Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C, Wilander E (2001) The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 37: 246-250
3. Boddeke F (1999) Quantitative fluorescence microscopy. PhD dissertation, Delft: Delft University
4. Bohmer G, van den Brule AJ, Brummer O, Meijer CL, Petry KU (2003) No confirmed case of human papillomavirus DNA-negative cervical intraepithelial neoplasia grade 3 or invasive primary cancer of the uterine cervix among 511 patients. Am J Obstet Gynecol 189: 118-120
5. Bortner DM, Rosenberg MP (1997) Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 17: 453-459
6. Darzynkiewicz Z, Gong J, Juan G, Ardelt B, Traganos F (1996) Cytometry of cyclin proteins. Cytometry 25: 1-13
7. Datta MW, Renshaw AA, Dutta A, Hoffman MA, Loughlin KR (2000) Evaluation of cyclin expression in testicular germ cell tumors: cyclin E correlates with tumor type, advanced clinical stage, and pulmonary metastasis. Mod Pathol 13: 667-672
8. Ekholm SV, Zickert P, Reed SI, Zetterberg A (2001) Accumulation of cyclin E is not a prerequisite for passage through the restriction point. Mol Cell Biol 21: 3256-3265
9. Ekholm-Reed S, Mendez J, Tedesco D, Zetterberg A, Stillman B, Reed SI (2004a) Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J Cell Biol 165: 789-800
10. Ekholm-Reed S, Spruck CH, Sangfelt O, van Drogen F, Mueller-Holzner E, Widschwendter M, Zetterberg A, Reed SI (2004b) Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer. Cancer Res 64: 795-800
11. Erlandsson F, Linnman C, Ekholm S, Bengtsson E, Zetterberg A (2000) A detailed analysis of cyclin A accumulation at the G(1)/S border in normal and transformed cells. Exp Cell Res 259: 86-95
12. Erlandsson F, Wahlby C, Ekholm-Reed S, Hellstrom AC, Bengtsson E, Zetterberg A (2003) Abnormal expression pattern of cyclin E in tumour cells. Int J Cancer 104: 369-375
13. Evans T, Rosenthal ET, Youngblom J, Distel D, Hunt T (1983) Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 33: 389-396
14. Keyomarsi K, Pardee AB (1993) Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90: 1112-1116
15. Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS (2002) Cyclin E and survival in patients with breast cancer. N Engl J Med 347: 1566-1575
16. Nakayama K, Nagahama H, Minamishima YA, Matsumoto M, Nakamichi I, Kitagawa K, Shirane M, Tsunematsu R, Tsukiyama T, Ishida N, Kitagawa M, Hatakeyama S (2000) Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J 19: 2069-2081
17. Nielsen NH, Loden M, Cajander J, Emdin SO, Landberg G (1999) G1-S transition defects occur in most breast cancers and predict outcome. Breast Cancer Res Treat 56: 105-112
18. Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841
19. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM (1997) Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3: 222-225
20. Schauenstein K, Schauenstein E, Wick G (1978) Fluorescence properties of free and protein bound fluorescein dyes. I. Macrospectrofluorometric measurements. J Histochem Cytochem 26: 277-283
21. Spruck CH, Won KA, Reed SI (1999) Deregulated cyclin E induces chromosome instability. Nature 401: 297-300